[PDF] Top 20 De Husserl a Levinas. Un camino en la fenomenología.
Has 2113 "De Husserl a Levinas. Un camino en la fenomenología." found on our website. Below are the top 20 most common "De Husserl a Levinas. Un camino en la fenomenología.".
Analysis on The Treatment of Colorectal Cancer
... A total of 51 studies were identified and inclusion criteria was applied as illustrated in Figure 1. After careful evaluation of titles, abstract, full text analysis and screening 5 studies were found to meet the ... See full document
132
Evolving role of cetuximab in the treatment of colorectal cancer
... in colorectal cancer has made significant progress in the recent ...for treatment guidance opened several new ...personalized treatment of cancer ... See full document
42
Role of oxaliplatin in the treatment of colorectal cancer
... until treatment failure; (2) mFOLFOX7 + bevacizumab for 4 months, than oxaliplatin was discontinued, and reintroduced after 4 months (or earlier in the case of tumor progression); (3) and (4): the same ... See full document
29
The Cost-Effectiveness of Combination Treatment Consisting of Either Cetuximab or Panitumumab plus FOLFIRI versus Treatment with Bevacizumab plus FOLFIRI as First-Line Treatment for KRAS Wild-Type Metastatic Colorectal Cancer Patients in Ontario
... on treatment line and the date each treatment was received, a PFS curve was able to be constructed from which monthly transition probabilities were eventually ...first-line treatment until death. ... See full document
6
The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials
... Subgroup analysis based on KRAS gene status revealed that the combined therapy significantly improved PFS (HR ...combined treatment also increased the incidence of grade 3/4 adverse ... See full document
8
Original Article The efficacy and toxicity of anti-VEGFR agents in the treatment of advanced colorectal cancer: a meta-analysis of randomized controlled trials
... the treatment of advanced colorectal cancer ...Sub-group analysis according to treatment lines showed that the addition of anti-VEGFR agents to second therapies significantly improved ... See full document
164
Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta analysis and system review
... patients. Analysis of the relationship between PCR-detectable metastases and survival has resulted in an adjusted five year survival of 91% in patients without minimal residual CRC and 50% in patients with minimal ... See full document
8
Perioperative transfusion and the prognosis of colorectal cancer surgery: a systematic review and meta analysis
... of cancer might affect the prognosis of colorectal cancer ...subgroup analysis, different types of surgical pro- cedure had different ...colon cancer or rectal cancer are taken ... See full document
221
The association between dietary protein intake and colorectal cancer risk: a meta analysis
... Several restrictions in this report should be attended. Firstly, our study included 21 individual studies; there- fore, many diversification such as adjustments and qual- ity that may influence the whole result. ... See full document
15
Treatment of metastatic colorectal cancer: focus on panitumumab
... Abstract: Targeted agents are an important therapeutic option in the treatment of metastatic colorectal cancer (mCRC). Panitumumab is a recombinant, fully humanized, immunoglobulin G2 monoclonal ... See full document
98
Metastatic Colorectal Cancer: Optimizing Treatment with Anti EGFR Monoclonal Antibody
... first-line treatment of metastatic colorectal cancer ...prospective analysis on treatment out- comes according to KRAS status was included only in the ... See full document
5
The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation
... cancers, colorectal cancer is the fourth most common morbidity caus- ing malignant tumor in the ...of colorectal cancer, it is always difficult to notice it in the early ...of ... See full document
10
Molecular profiling in the treatment of colorectal cancer: focus on regorafenib
... Metastatic colorectal cancer (mCRC) is a highly heterogeneous ...Its treatment outcome has been significantly improved over the last decade with the incorporation of biological targeted therapies, ... See full document
26
Emergency treatment of complicated colorectal cancer
... a colorectal surgeon may not be immediately available if the patient presents out of ...the cancer and its complication in one go with a resection in ... See full document
12
Analysis of the clinical significance of DCLK1<sup>+</sup> colorectal cancer using novel monoclonal antibodies against DCLK1
... epitope analysis, the DCLK1-87 mAb epitope was consistent with a commercial DCLK1 polyclonal antibody; thus, we used DCLK1-87 to perform IHC on CRC tissue slides and found that DCLK1-87 was more specific for DCLK1 ... See full document
7
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial
... Methods In FOCUS4-D, we included patients from 18 hospitals in the UK with newly diagnosed advanced or metastatic colorectal cancer whose tumour was wild-type for BRAF, PIK3CA, KRAS, and NRAS. After 16 ... See full document
35
Quality of life of early stage colorectal cancer patients in Morocco
... early colorectal cancer patients, in Morocco, and also in North ...specific cancer treatment (chemotherapy and/or radiotherapy), at one year, when acute treatment effects are expected ... See full document
10
Review Article Lack of association between LCT-13910 C/T (rs4988235) polymorphism and risk of colorectal cancer: evidence from case-control studies
... and colorectal cancer ...and colorectal cancer susceptibility were included from PubMed, Embase, Web of Science, and Cochrane ...and colorectal cancer susceptibility in the ... See full document
105
Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer
... univariate analysis. In the multivariate Cox analysis of OS, gender, TNM staging, uric acid were independent predictive risk factors for the prognosis of NMCRC patients after adjustment for tumor ... See full document
54
Cross-Stratification and Differential Risk by Breast Cancer Index and Recurrence Score in Women with Hormone Receptor-Positive Lymph Node-Negative Early-Stage Breast Cancer.
... breast cancer who did not receive chemotherapy as part of their initial treatment, and who were randomised to either anastrozole or tamoxifen ...this analysis, only women with lymph node-negative ... See full document
9
Related subjects